Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024 Bioxyne was hit with an impairment charge of A$11.5 million in the first half of FY24 […]
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024
Company news: Little Green Pharma; MGC Pharma; Medlab Clinical; Creso Pharma by Martin Lane February 9, 2023April 29, 2024
Company news: Helius Therapeutics; Little Green Pharma; MGC Pharma; Incannex by Martin Lane and Steve Jones December 7, 2022April 29, 2024
